Swallowing rehabilitation by rhyth… for Parkinson's (NCT06695455)
Reduce tongue rolling during swallowing
- Trial ID
- NCT06695455
- Official Title
- The Effect of an Auditory Rhythmic Cue on the Frequency of Rolling in Patients with Dysphagia and Parkinson's Disease: a Pilot Study
- Goal
- Reduce tongue rolling during swallowing
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Hopital La Musse
- Study Type
- INTERVENTIONAL
- Enrollment
- 18 participants
- Conditions
- Oral Festination, Lingual Pumping, Dysphagia, Swallowing Disorder, PARKINSON DISEASE (Disorder)
- Interventions
- Swallowing rehabilitation by rhythmic auditory cue
Summary For Families
Researchers are asking whether adding rhythmic sounds during swallowing rehab can reduce how often rolling, an involuntary back-and-forth tongue movement just before swallowing, happens in people with Parkinson's who have trouble swallowing, and they will measure this using swallowing radiography. Participants will come to supervised speech therapy sessions three times a week for seven weeks where rhythmic auditory cueing is used during exercises; this approach has helped reduce freezing of gait and is now being tested for rolling. Swallowing will be checked before the program, right after it finishes, and again three months later, with a focus on the oral phase. The study is looking for adults 18 and older with Parkinson's diagnosed by a neurologist and a DAT scan who have rolling and can hear the cues; people with severe pharyngeal swallowing problems, major cognitive impairment, profound hearing loss, ongoing swallowing therapy, or certain other medical reasons will not qualify.
Locations
- Hôpital La Musse - La Renaissance Sanitaire, Saint-Sébastien-de-Morsent, Normandy, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Swallowing rehabilitation by rhythmic auditory cue. Researchers are asking whether adding rhythmic sounds during swallowing rehab can reduce how often rolling, an involuntary back-and-forth tongue movement just before swallowing, happens in people with Parkinson's who have trouble swallowing, and they will measure this using swallowing radiography. Participants will come to supervised speech therapy sessions three times a week for seven weeks where rhythmic auditory cueing is used during exercises; this approach has helped reduce freezing of gait and is now being tested for rolling. Swallowing will be checked before the program, right after it finishes, and again three months later, with a focus on the oral phase. The study is looking for adults 18 and older with Parkinson's diagnosed by a neurologist and a DAT scan who have rolling and can hear the cues; people with severe pharyngeal swallowing problems, major cognitive impairment, profound hearing loss, ongoing swallowing therapy, or certain other medical reasons will not qualify.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- You must perform three complete assessments (before the protocol, after the protocol, and 3 months post-protocol) and attend sessions three times per week for 7 weeks at the La Musse hospital.